Form 4: Tyra Biosciences CFO Alan Fuhrman Reports Acquisition of Common Stock

Alan Fuhrman, CFO of Tyra Biosciences, reports acquiring 932 shares of common stock through the company's Employee Stock Purchase Plan.

Summary

• On March 15, 2024, Alan Fuhrman, the Chief Financial Officer of Tyra Biosciences, acquired 932 shares of common stock.
• The shares were purchased at a price of $12.478 per share.
• The acquisition was made under the Issuer's 2021 Employee Stock Purchase Plan.
• Following the transaction, Fuhrman directly owns 2,395 shares of Tyra Biosciences common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports an insider transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The CFO's participation in the Employee Stock Purchase Plan could be seen as a positive signal, indicating confidence in the company's future.

Industry Context

This filing is a routine disclosure related to insider transactions and is a common occurrence for publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, primarily providing transparency to shareholders regarding insider trading activity.

Key Dates